It has been clarified, in our department, by use of coronary catheterization, that coronary insuf-ficiency is essentially concerned with myocardial metabolism, and that various coronary vasodilators can not increase coronary blood flow in sclerotic coronary heart diseases so well as in healthy persons. Moreover in cases of myocardial infarction the coronary blood flow is reduced and myocardial oxygen consumption was decreased. In this paper, peculiarities of carbohydrate nary metabolism in ischemic heart diseases and the influence of coronary vasodilators upon it were investigated, to find the clinicopathopharmacological principle of therapy for coronary insufficiency by coronary vasodilators. Methods:The blood from femoral artery and from coronary sinus taken with coronary sinus cathet-erization were analyzed as follows. Blood glucose was determined by the method of Somogyi or glucose oxydase, lactate by hydroxydiphenyl method after Barker and Summerson and pyruvate by dinitrophenylhydrazine method after Friedemann and Haugen. Coronary blood flow was measured by the nitrous oxide method and myocardial oxygen consumption by the Van Slyke Neill method. Resting myocardial carbohydrate metabolism were measured in 89 cases, namely, 16 controls (5 normal, 6 slight pulmonary tuberculosis and 5 with no evidence of sickness in the main organs), 20 noncoronary heart diseases (chiefly various valvular diseases), 10 hypertension (with or without coronary insufficiency), 26 coronary diseases (old myocardial infarct and coronary insufficiency without hypertension) and 17 hepatic myocardosis (chiefly liver cirrhosis). In 45 of these cases, the myocardial carbohydrate metabolism after administration of various coronary vasodilators were measured also. Coronary vasodilators examined were Dipyridamole, Carbochromene, PF-26, Iproveratril, Xanthine derivatives, Benziodarone and Isosorbide dinitrate. Results: A) Myocardial carbohydrate metabolism in the resting state (Table I) 1) Glucose The myocardial extraction, the extraction ratio and the usage of glucose in noncoronary heart diseases were higher significantly than in other groups. Those in hypertension showed a low tendency. 2) Lactate The myocardial extraction, extraction ratio and usage of lactate in hypertension showed a lower tendency compared with other groups. 3) Pyruvate The same tendency seen in lactate was observed also in pyruvate of hypertension group.
View full abstract